We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNG icon
1701
Scorpio Tankers
STNG
$3.93B
$259K ﹤0.01%
23,411
AGEN
1702
Agenus
AGEN
$315M
$259K ﹤0.01%
3,294
ARR
1703
Armour Residential REIT
ARR
$2.37B
$258K ﹤0.01%
5,427
KIDS icon
1704
OrthoPediatrics
KIDS
$653M
$258K ﹤0.01%
5,617
SGRY icon
1705
Surgery Partners
SGRY
$1.99B
$258K ﹤0.01%
11,767
AGX icon
1706
Argan
AGX
$7.84B
$257K ﹤0.01%
6,140
BFX
1707
DELISTED
BowFlex Inc.
BFX
$256K ﹤0.01%
14,931
BALY icon
1708
Bally's
BALY
$660M
$256K ﹤0.01%
9,752
CAC icon
1709
Camden National
CAC
$996M
$256K ﹤0.01%
8,459
MYRG icon
1710
MYR Group
MYRG
$5.1B
$256K ﹤0.01%
6,874
VAPO
1711
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$255K ﹤0.01%
1,101
KELYA icon
1712
Kelly Services Class A
KELYA
$566M
$255K ﹤0.01%
14,944
VIE
1713
DELISTED
Viela Bio, Inc. Common Stock
VIE
$254K ﹤0.01%
9,054
RLMD icon
1714
Relmada Therapeutics
RLMD
$507M
$254K ﹤0.01%
6,754
ANDE icon
1715
Andersons Inc
ANDE
$2.21B
$254K ﹤0.01%
13,251
ZUMZ icon
1716
Zumiez
ZUMZ
$319M
$253K ﹤0.01%
9,084
ALX
1717
Alexander's
ALX
$1.4B
$252K ﹤0.01%
1,029
DENN
1718
DELISTED
Denny's
DENN
$252K ﹤0.01%
25,229
ENVA icon
1719
Enova International
ENVA
$6.52B
$252K ﹤0.01%
15,391
PRVB
1720
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$252K ﹤0.01%
19,627
BGC icon
1721
BGC Group
BGC
$5.2B
$252K ﹤0.01%
104,908
-35,686
-25% -$93.2K
ANIK icon
1722
Anika Therapeutics
ANIK
$283M
$251K ﹤0.01%
7,087
CNST
1723
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$251K ﹤0.01%
12,376
PBF icon
1724
PBF Energy
PBF
$8.81B
$251K ﹤0.01%
44,028
-60,566
-58% -$502K
FLWS icon
1725
1-800-Flowers.com
FLWS
$261M
$250K ﹤0.01%
10,044
-3,286
-25% -$86.9K

Similar funds

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.